Cargando…

FS-93, an Hsp90 inhibitor, induces G2/M arrest and apoptosis via the degradation of client proteins in oncogene addicted and derived resistant cancer cells

Inhibition of heat shock protein 90 (Hsp90) abrogates signaling of multiple aberrantly activated oncogenic proteins simultaneously, particularly mutated or amplified kinases, which provides an attractive approach for cancer treatment. Here, we described that FS-93, a potent Hsp90 inhibitor, impacted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Liping, Shen, Aijun, Wang, Lu, Liu, Hongchun, Chen, Danqi, Xiong, Bing, Shen, Jingkang, Geng, Meiyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468327/ https://www.ncbi.nlm.nih.gov/pubmed/26097875

Ejemplares similares

Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
por: Chen, Danqi, et al.
Publicado: (2016)

Hsp90 (Heat Shock Protein 90) Inhibitor Occupancy Is a Direct Determinant of Client Protein Degradation and Tumor Growth Arrest in Vivo
por: Tillotson, Bonnie, et al.
Publicado: (2010)

Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagy
por: Shen, Shensi, et al.
Publicado: (2009)

Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery
por: Li, Ting, et al.
Publicado: (2018)

Hsp110 Chaperones Control Client Fate Determination in the Hsp70–Hsp90 Chaperone System
por: Mandal, Atin K., et al.
Publicado: (2010)

HECTD3 Mediates an HSP90-Dependent Degradation Pathway for Protein Kinase Clients
por: Li, Zhaobo, et al.
Publicado: (2017)

Author Correction: Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells
por: Wang, Yue-qin, et al.
Publicado: (2020)

SUV39H1 is a New Client Protein of Hsp90 Degradated by Chaetocin as a Novel C-Terminal Inhibitor of Hsp90
por: Lian, Bin, et al.
Publicado: (2021)

The APE2 Exonuclease Is a Client of the Hsp70–Hsp90 Axis in Yeast and Mammalian Cells
por: Omkar, Siddhi, et al.
Publicado: (2022)

Summary notes of the CLIC/FS meeting 29/10/93
por: Madsen, J H B
Publicado: (1993)

Immunotherapeutic targeting of HSP90 client proteins in BRAF-inhibitor resistant melanoma
por: Fecek, Ronald J, et al.
Publicado: (2015)

A switch point in the molecular chaperone Hsp90 responding to client interaction
por: Rutz, Daniel Andreas, et al.
Publicado: (2018)

The Hsp90 isoforms from S. cerevisiae differ in structure, function and client range
por: Girstmair, Hannah, et al.
Publicado: (2019)

Hsp70 Forms Antiparallel Dimers Stabilized by Post-translational Modifications to Position Clients for Transfer to Hsp90
por: Morgner, Nina, et al.
Publicado: (2015)

Sulphoxythiocarbamates modify cysteine residues in HSP90 causing degradation of client proteins and inhibition of cancer cell proliferation
por: Zhang, Y, et al.
Publicado: (2014)

Resistance to HSP90 inhibition involving loss of MCL1 addiction
por: Busacca, S, et al.
Publicado: (2016)

Genome-scale Co-evolutionary Inference Identifies Functions and Clients of Bacterial Hsp90
por: Press, Maximilian O., et al.
Publicado: (2013)

ETV6/FLT3 Fusion Is a Novel Client Protein of Hsp90
por: Ly, Bui Thi Kim, et al.
Publicado: (2018)

Client binding shifts the populations of dynamic Hsp90 conformations through an allosteric network
por: Lopez, Abraham, et al.
Publicado: (2021)

HspB1, HspB5 and HspB4 in Human Cancers: Potent Oncogenic Role of Some of Their Client Proteins
por: Arrigo, André-Patrick, et al.
Publicado: (2014)

Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition
por: Poole, Candace J., et al.
Publicado: (2018)

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins
por: Smith, Jennifer R., et al.
Publicado: (2013)

Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell Lymphomas
por: Calvo-Vidal, M. Nieves, et al.
Publicado: (2021)

A novel mode of action for COX‐2 inhibition: Targeting ATPase domain of HSP90 induces ubiquitin degradation of new client protein COX‐2
por: Zhang, Man, et al.
Publicado: (2022)

Distinct Roles of Molecular Chaperones HSP90α and HSP90β in the Biogenesis of KCNQ4 Channels
por: Gao, Yanhong, et al.
Publicado: (2013)

C0818, a novel curcumin derivative, interacts with Hsp90 and inhibits Hsp90 ATPase activity
por: Fan, Yingjuan, et al.
Publicado: (2017)

A selenosemicarbazone complex with copper efficiently down-regulates the 90-kDa heat shock protein HSP90AA1 and its client proteins in cancer cells
por: Shen, Hongtao, et al.
Publicado: (2014)

Silencing the cochaperone CDC37 destabilises kinase clients and sensitises cancer cells to HSP90 inhibitors
por: Smith, Jennifer R., et al.
Publicado: (2008)

The client protein p53 forms a molten globule-like state in the presence of Hsp90
por: Park, Sung Jean, et al.
Publicado: (2011)

Kdm3a lysine demethylase is an Hsp90 client required for cytoskeletal rearrangements during spermatogenesis
por: Kasioulis, Ioannis, et al.
Publicado: (2014)

Allosteric Regulation of the Hsp90 Dynamics and Stability by Client Recruiter Cochaperones: Protein Structure Network Modeling
por: Blacklock, Kristin, et al.
Publicado: (2014)

Phosphorylation induced cochaperone unfolding promotes kinase recruitment and client class-specific Hsp90 phosphorylation
por: Bachman, Ashleigh B., et al.
Publicado: (2018)

Spermatogenesis arrest caused by conditional deletion of Hsp90α in adult mice
por: Kajiwara, Chiaki, et al.
Publicado: (2012)

17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells
por: Karkoulis, Panagiotis K, et al.
Publicado: (2010)

Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9
por: Jiang, Min, et al.
Publicado: (2013)

Bacterial Hsp90 Facilitates the Degradation of Aggregation-Prone Hsp70–Hsp40 Substrates
por: Fauvet, Bruno, et al.
Publicado: (2021)

The activity of protein phosphatase 5 towards native clients is modulated by the middle- and C-terminal domains of Hsp90
por: Haslbeck, Veronika, et al.
Publicado: (2015)

The disruption of protein−protein interactions with co-chaperones and client substrates as a strategy towards Hsp90 inhibition
por: Serwetnyk, Michael A., et al.
Publicado: (2021)

Development of the first geldanamycin-based HSP90 degraders
por: Wurnig, Silas, et al.
Publicado: (2023)

Pharmacologic inhibition of Hsp90 to prevent GLT-1 degradation as an effective therapy for epilepsy
por: Sha, Longze, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_541geienpnr2u16i77ir420og2